“These outcomes have essential implications,” mentioned research co-author Shyam Raman. He’s a doctoral pupil within the Faculty of Public Coverage at Cornell College in Ithaca, N.Y.
“The reductions in drug utilization that we discover may result in vital price financial savings for state Medicaid packages. The outcomes additionally point out a chance to cut back the hurt that may include the damaging unwanted effects related to some pharmaceuticals,” Raman mentioned in a college information launch.
For the research, the researchers analyzed U.S. Facilities for Medicare and Medicaid Companies information collected from all states from 2011 to 2019, when there was a rise in states that let private marijuana use.
Presently, leisure marijuana use is authorized in 18 states plus Washington, D.C. Thirty-seven states plus Washington, D.C., have legalized medical marijuana.
Most earlier analysis has centered on how medical marijuana impacts prescription drug use or how authorized leisure pot use impacts opioid demand. This is likely one of the first papers to look at the affect of authorized leisure marijuana on prescription drug use, the research authors famous.
Whereas there’s a constructive side to their findings, the investigators warned that marijuana use carries dangers, pointing to quite a lot of research that join it with potential triggering of hysteria and psychoses equivalent to schizophrenia.
There’s additionally the prospect that individuals who use marijuana to deal with their well being issues might not see their physician as usually, leading to gaps of their major care, the researchers mentioned.
The research was revealed April 15 within the journal Well being Economics .
There’s extra on marijuana on the U.S. Nationwide Institute on Drug Abuse.
SOURCE: Cornell College, information launch, April 18, 2022